NFO period: 10^th Nov - 24^th Nov, 2025

Highlights of the NFO:

• Scheme type - An open ended equity scheme investing in Banking and Financial Services sector


• Investment objective - The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. There is no assurance or guarantee that the scheme's objectives will be realised.


• Product suitability - This product is suitable for investors who are seeking to create wealth over a long term. Investment predominantly in equity and equity related instruments of pharma, healthcare and allied companies.


• Minimum Application Amount - Rs. 1000 and in multiples of Re. 1/- thereafter


• Plan/ Options available - Regular plan & Direct plan having Growth Option and Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of Income Distribution cum capital withdrawal option and Reinvestment of Income Distribution cum capital withdrawal option).


• Fund Managers - Mr. Viraj Kulkarni & Mr. Brijesh Shah


• Benchmark - BSE Healthcare TRI